Clinical Center; Notice of Meeting, 13243 [E8-4654]

Download as PDF Federal Register / Vol. 73, No. 49 / Wednesday, March 12, 2008 / Notices Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892. (Virtual Meeting) Contact Person: Noni Byrnes, PhD, Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5130, MSC 7840, Bethesda, MD 20892, (301) 435– 1023, byrnesn@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research; 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS). Dated: March 4, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E8–4649 Filed 3–11–08; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Clinical Center; Notice of Meeting pwalker on PROD1PC71 with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of the NIH Advisory Board for Clinical Research. The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meeting will be closed to the public in accordance with the provisions set forth in section 552b(c)(6), Title 5 U.S.C., as amended to discuss personnel matters, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: NIH Advisory Board for Clinical Research. Date: March 31, 2008. Open: 10 a.m. to 12:45 p.m. Agenda: To review budget and policy issues at the NIH Clinical Center. Place: National Institutes of Health, Building 10, 10 Center Drive, Room 4–2551, Bethesda, MD 20892. Closed: 12:45 p.m. to 2 p.m. Agenda: To review and evaluate personnel matters. Place: National Institutes of Health, Building 10, 10 Center Drive, Room 4–2551, Bethesda, MD 20892. Contact Person: Maureen E. Gormley, Executive Secretary, Mark O. Hatfield Clinical Research Center, National Institutes of Health, Building 10, Room 6–2551, Bethesda, MD 20892, 301/496–2897. VerDate Aug<31>2005 19:30 Mar 11, 2008 Jkt 214001 13243 Dated: March 4, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E8–4654 Filed 3–11–08; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES BILLING CODE 4140–01–M Fiscal Year (FY) 2008 Funding Opportunity DEPARTMENT OF HEALTH AND HUMAN SERVICES AGENCY: National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel R13 Conference Applications. Date: April 2, 2008. Time: 8 a.m. to 11 a.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6700B, Rockledge Drive, 3147, Bethesda, MD 20892. (Telephone Conference Call) Contact Person: Michelle M. Timmerman, PhD, Scientific Review Officer, Scientific Review Program, National Institutes of Health/NIAID, Room 3258, 6700B Rockledge Drive, MSC–7616, Bethesda, MD 20892– 7616, 301–451–4573, timmermanm@niaid.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS). Dated: March 4, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E8–4652 Filed 3–11–08; 8:45 am] BILLING CODE 4140–01–M PO 00000 Frm 00054 Fmt 4703 Sfmt 4703 Substance Abuse and Mental Health Services Administration Substance Abuse and Mental Health Services Administration, HHS. ACTION: Notice of intent to award a Single Source Grant to the National Association of State Alcohol and Drug Abuse Directors (NASADAD). SUMMARY: This notice is to inform the public that the Substance Abuse and Mental Health Services Administration (SAMHSA) intends to award approximately $600,000 (total costs) per year for up to three years to the National Association of State Alcohol and Drug Abuse Directors (NASADAD). This is not a formal request for applications. Assistance will be provided only to the National Association of State Alcohol and Drug Abuse Directors (NASADAD) based on the receipt of a satisfactory application that is approved by an independent review group. Funding Opportunity Title: TI–08– 002. Catalog of Federal Domestic Assistance (CFDA) Number: 93.243. Authority: Section 1935 of the Public Health Service Act, as amended. Justification: Only the National Association of State Alcohol and Drug Abuse Directors (NASADAD) is eligible to apply. The Substance Abuse and Mental Health Services Administration (SAMHSA) is seeking to award a single source grant to the National Association of State Alcohol and Drug Abuse Directors (NASADAD) to facilitate collaborative activities between SAMHSA and the States to assist SAMHSA in its development and implementation of the National Outcome Measures (NOMs). NASADAD’s membership is composed of the State substance abuse authorities (SSAs). SSAs are the recipients of SAMHSA’s Substance Abuse Prevention and Treatment (SAPT) Block Grant funds. Grant activities will focus on areas of mutual interest and will help support the States’ ability to respond to changes brought about by the transition of management of the SAPT Block Grant to a performance and outcomes focus based upon the NOMs and other information. These collaborative activities will assist SAMHSA in its development, implementation and management of the SAPT Block Grant Program, and will assist States in the E:\FR\FM\12MRN1.SGM 12MRN1

Agencies

[Federal Register Volume 73, Number 49 (Wednesday, March 12, 2008)]
[Notices]
[Page 13243]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-4654]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Clinical Center; Notice of Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of 
the NIH Advisory Board for Clinical Research.
    The meeting will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the Contact Person 
listed below in advance of the meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in section 552b(c)(6), Title 5 U.S.C., as amended 
to discuss personnel matters, the disclosure of which would constitute 
a clearly unwarranted invasion of personal privacy.

    Name of Committee: NIH Advisory Board for Clinical Research.
    Date: March 31, 2008.
    Open: 10 a.m. to 12:45 p.m.
    Agenda: To review budget and policy issues at the NIH Clinical 
Center.
    Place: National Institutes of Health, Building 10, 10 Center 
Drive, Room 4-2551, Bethesda, MD 20892.
    Closed: 12:45 p.m. to 2 p.m.
    Agenda: To review and evaluate personnel matters.
    Place: National Institutes of Health, Building 10, 10 Center 
Drive, Room 4-2551, Bethesda, MD 20892.
    Contact Person: Maureen E. Gormley, Executive Secretary, Mark O. 
Hatfield Clinical Research Center, National Institutes of Health, 
Building 10, Room 6-2551, Bethesda, MD 20892, 301/496-2897.

    Dated: March 4, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
 [FR Doc. E8-4654 Filed 3-11-08; 8:45 am]
BILLING CODE 4140-01-M

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.